59 related articles for article (PubMed ID: 1774434)
1. Effects of the new immunoactive compound FCE 20696 on rat and murine models of autoimmune diseases.
Isetta AM; Ferrari M; Fornasiero MC; Trizio D
Immunopharmacol Immunotoxicol; 1991; 13(4):499-511. PubMed ID: 1774434
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D.
Matsumoto Y; Fujiwara M
Cell Immunol; 1993 Jul; 149(2):268-78. PubMed ID: 7687198
[TBL] [Abstract][Full Text] [Related]
3. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis.
Lange F; Bajtner E; Rintisch C; Nandakumar KS; Sack U; Holmdahl R
Ann Rheum Dis; 2005 Apr; 64(4):599-605. PubMed ID: 15345503
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Ben-Nun A; Kalland T; Abramsky O
Ann Neurol; 1993 Nov; 34(5):654-60. PubMed ID: 8239559
[TBL] [Abstract][Full Text] [Related]
6. Antigen specific, suppressor cells induced by the immunomodulator FCE 20696 in aged NZB/WF1 mice.
Fornasiero MC; Isetta AM; Ferrari M; Trizio D
Agents Actions; 1986 Dec; 19(5-6):315-7. PubMed ID: 2950736
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis.
Cavaletti G; Perseghin P; Buscemi F; Dassi M; Oggioni N; Sala F; Lolli F; Liuzzi GM; Riccio P; Frattola L; Tredici G
Int J Tissue React; 2001; 23(1):21-31. PubMed ID: 11392060
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
Killen JA; Swanborg RH
J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells exposed to estrogen in vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis.
Pettersson A; Ciumas C; Chirsky V; Link H; Huang YM; Xiao BG
J Neuroimmunol; 2004 Nov; 156(1-2):58-65. PubMed ID: 15465596
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of immunoglobulin treatment in rats with experimental allergic encephalomyelitis].
Mel'nyk VO; Lisianyĭ MI; Biel's'ka LM; Shniakin SA
Fiziol Zh (1994); 2005; 51(6):37-9. PubMed ID: 16485852
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE).
Schorlemmer HU; Bartlett RR
Drugs Exp Clin Res; 1997; 23(5-6):175-81. PubMed ID: 9515227
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
[TBL] [Abstract][Full Text] [Related]
14. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
Milicevic I; Pekovic S; Subasic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Medic-Mijacevic L; Pejanovic V; Rakic L; Stojiljkovic M
J Neurosci Res; 2003 Apr; 72(2):268-78. PubMed ID: 12672002
[TBL] [Abstract][Full Text] [Related]
15. Enkephalins and autoimmunity: differential effect of methionine-enkephalin on experimental allergic encephalomyelitis in Wistar and Lewis rats.
Janković BD; Marić D
J Neurosci Res; 1987; 18(1):88-94. PubMed ID: 3500326
[TBL] [Abstract][Full Text] [Related]
16. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo immunopharmacological profile of Sch 40120.
Smith SR; Watnick AS; Kung T; Siegel MI
Immunopharmacol Immunotoxicol; 1993 Jan; 15(1):13-44. PubMed ID: 8450179
[TBL] [Abstract][Full Text] [Related]
18. T lymphocyte clones and experimental autoimmune diseases.
Cohen IR
Behring Inst Mitt; 1985 Aug; (77):88-92. PubMed ID: 2417586
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity.
Hershkoviz R; Mor F; Miao HQ; Vlodavsky I; Lider O
J Autoimmun; 1995 Oct; 8(5):741-50. PubMed ID: 8579728
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
Li XB; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
